Related by context. Frequent words. (Click for all words.) 72 ASCO Annual Meeting 71 ICAAC 70 AACR NCI EORTC 68 Clinical Trial Results 68 Pharmacokinetic 68 Solid Tumors 68 Breast Cancer Symposium 67 EORTC 66 AASLD 66 EASL 66 Transcatheter Cardiovascular Therapeutics TCT 65 EORTC NCI AACR Symposium 65 EuroPCR 65 nab paclitaxel 65 Digestive Disease Week 64 Pivotal Phase III 64 substudy 64 Poster Presentation 64 HER2 positive metastatic breast 64 Immunogenicity 63 Phase 1b trial 63 axitinib 63 Digestive Disease Week DDW 63 subgroup analyzes 63 Clinical Oncology Annual Meeting 63 Oral Presentation 63 Bortezomib 63 Tolerability 63 Chronic Hepatitis C 63 Molecular Targets 63 tipranavir 62 Azedra 62 San Antonio Breast Cancer 62 ESMO 62 placebo controlled clinical 62 FOLFIRI 62 Annual Scientific Sessions 62 Monotherapy 62 RTOG 62 Phase III Trial 62 Hematology Annual Meeting 62 ARVO 61 PXD# 61 dose escalation trial 61 CR# vcMMAE 61 Poster Session 61 EASD 61 Postmenopausal Women 61 ASCO 61 Taxotere ® 61 Pivotal Trial 61 phase IIb 61 Phase 1b 61 Heart Failure Patients 61 Pharmacokinetics 61 League Against Rheumatism 61 Abstract # 61 randomized Phase III 61 Meta Analysis 61 decitabine 60 CoFactor 60 glatiramer acetate 60 J Clin Oncol 60 secondary efficacy endpoints 60 SPIRIT III 60 Phase 2b study 60 LymphoStat B 60 neoadjuvant 60 phase 2a 60 elagolix 60 Phase 2b 60 Gemcitabine 60 Taxotere R 60 plus prednisone 60 aflibercept 60 tanespimycin 60 Bladder Cancer 60 phase IIa 60 Patients Treated 59 Drug Candidate 59 Phase 2a clinical 59 metastatic renal cell carcinoma 59 Trastuzumab 59 chemoradiotherapy 59 Patient Recruitment 59 Clinical Oncology ASCO Annual 59 pharmacodynamic 59 RGB # 59 prospective observational 59 Chronic Lymphocytic Leukemia 59 Bevacizumab 59 rNAPc2 59 ponatinib 59 EULAR 59 HGS ETR1 59 DDW 59 BCX# 59 TYKERB 59 FDG PET 59 refractory multiple myeloma 59 REVLIMID R